Agata Krygowska

Agata Krygowska is a highly experienced scientist specializing in oncology and cancer biology, currently serving as Lead Senior Scientist at Nexus BioQuest since March 2025. Prior roles include Senior Scientist II, Senior Scientist I, and Senior Scientist at Achilles Therapeutics plc from April 2021 to November 2024, and a Scientist position at Adaptimmune from October 2018 to April 2021. Agata's research expertise focuses on novel therapeutic approaches for lung cancer treatment, with significant experience in murine models and tumor immune population analysis. Educational qualifications include a Doctor of Philosophy in Oncology and Cancer Biology from Queen Mary University of London and a Master of Science in the same field from the University of Silesia in Katowice. Additionally, Agata has contributed to the Marie Curie initial training TIMCC network as an Early Stage Researcher and served as a Research Technician at Barts Cancer Institute.